PharmaEssentia Medical Affairs
The PharmaEssentia Medical Affairs team is a strategic thought partner dedicated to providing comprehensive educational, clinical, and scientific information about PharmaEssentia therapies and areas of interest, and engaging in meaningful discussions with healthcare professionals and key stakeholders about our pipeline and the unmet medical needs in myeloproliferative neoplasms.
The transformative and actionable insights gained through scientific exchange lead to the development of innovative evidence-generation strategies and educational opportunities.
This site may include information on investigational products or uses that have not been approved by the US FDA. PharmaEssentia does not support, endorse, or recommend the unapproved use of any compound. This site includes information on clinical trials for approved and investigational compounds and indications. This information is not intended to be medical advice. By using this website, you confirm the unsolicited nature of your request.
Learn more about PharmaEssentia Medical Affairs
This site and all materials are intended for US healthcare professionals as a nonpromotional resource for medical and scientific information and noncertified medical education purposes only.
- PharmaEssentia USA Corporation
- 35 Corporate Drive, Suite 325,
- Burlington, MA 01803, USA
- © 2023 PharmaEssentia Corporation. All rights reserved.
- PharmaEssentia and the PharmaEssentia logo are trademarks or registered trademarks of PharmaEssentia Corporation.
- MED-US-RPEG-2200019 (v1.0) 06/2023
You are now leaving this site and being directed to a site not maintained by PharmaEssentia.
PharmaEssentia is not responsible for content or privacy policies on other sites.